Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Respiratory and ...

Patients with severe COVID-19 who require venovenous extracorporeal membrane oxygenation (VV-ECMO) support can, if carefully selected and managed, obtain “exceptional survival” approaching 87% at 1 ...

Packed red blood cell transfusion improved survival among adults with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation when using a hemoglobin threshold of less ...

Some patients with severe COVID-19 who are treated with extracorporeal membrane oxygenation (ECMO) may experience significant lung recovery and return to normal lives with 'meaningful' long-term ...

A notable proportion of patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) for acute respiratory failure developed acute kidney injury (AKI), likely due to the greater severity ...

Patients with severe Covid-19, if treated with extracorporeal membrane oxygenation (ECMO), may see a major improvement in lung recovery, making their return to normal lives much faster, a study, ...

Ephraim McDowell Regional Medical Center (EMRMC) has been designated a Silver Level Center on the Pathway to Excellence in ...

To describe the use of double-lumen venovenous (VVDL) extracorporeal membrane oxygenation (ECMO) with cephalic draining cannula (VVDL+V) as a primary approach for all neonatal respiratory diagnoses ...

Please provide your email address to receive an email when new articles are posted on . A high effort to eliminate carbon dioxide was linked to a greater likelihood of failing to wean from venovenous ...

Many extracorporeal membrane oxygenation (ECMO) patients experienced long-term neuropsychiatric symptoms, cognitive impairment, or functional impairment, a meta-analysis found. Fully 41% of ECMO ...